BioGaia AB (publ)
BGLAF
$10.24
-$0.18-1.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.14M | 27.73M | 29.01M | 33.21M | 31.96M |
| Total Depreciation and Amortization | 2.55M | 7.43M | 7.36M | 7.33M | 7.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.65M | -1.44M | -507.30K | -462.40K | 3.48M |
| Change in Net Operating Assets | 1.35M | -3.30M | -2.30M | -4.87M | -5.55M |
| Cash from Operations | 32.38M | 30.41M | 33.56M | 35.21M | 37.20M |
| Capital Expenditure | -281.60K | -442.90K | -536.80K | -1.32M | -2.63M |
| Sale of Property, Plant, and Equipment | 7.40K | 7.40K | 7.40K | 7.40K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.40K | -43.60K | -38.50K | -36.80K | -5.60K |
| Cash from Investing | -317.50K | -479.00K | -567.80K | -1.35M | -2.63M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.78M | -8.27M | -8.87M | -9.36M | -10.04M |
| Issuance of Common Stock | 0.00 | 20.82M | 20.82M | 20.82M | 20.82M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -72.25M | -72.25M | -65.17M | -65.17M | -65.17M |
| Other Financing Activities | -504.91M | -509.31M | -509.31M | -509.31M | -155.22M |
| Cash from Financing | -73.01M | -71.47M | -64.43M | -64.48M | -64.96M |
| Foreign Exchange rate Adjustments | -318.40K | -582.80K | -384.00K | 966.60K | -770.40K |
| Miscellaneous Cash Flow Adjustments | -100.00 | -100.00 | -- | -- | -- |
| Net Change in Cash | -41.26M | -42.12M | -31.82M | -29.65M | -31.17M |